Q3C Tables and List Rev 4
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 1, 2018
February 25, 2022
603912c9-dba1-4b46-ba60-7454fec624a0
Related Documents
E8(R1) General Considerations for Clinical Studies
Guidance DocumentApril 8, 2022Center for Drug Evaluation and Research
Labeling for Biosimilar Products Guidance for Industry
Guidance DocumentJuly 18, 2018Center for Drug Evaluation and Research
M4E(R2): The CTD – Efficacy
Guidance DocumentJuly 24, 2017Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.